The Advanced Clinical Research Center was established to build advanced medical facilities and treatment systems, and to foster medical professionals who will contribute to the world. It is a research facility that can conduct everything from the production and synthesis of radiopharmaceuticals to non-clinical testing, clinical research, and trials. As part of our efforts to provide safe and secure medical care to the people of the prefecture, we are working to realize the next generation of therapies, Theranotics, which is a fusion of Therapy and Diagnosis. In order to achieve this goal, we conduct development of new drugs in collaboration with domestic and overseas researchers and research institutions.
In addition, equipped with Japan’s only medium-sized cyclotron that is specialized for the manufacture of medical radioisotopes (nuclides), the Center has succeeded in the stable production of Astatine-211 ( 211At), which is attracting attention as an alpha-emitting nuclide that has the effect of killing cancer cells, in quantities and quality levels that can be used in nuclear medical treatment, and we are moving ahead with the research and development and clinical trials of therapeutic drugs.
Furthermore, we are collaborating with the Fukushima institute for Research, Education and Innovation (F-REI), established by the government in Namie-machi in the Fukushima Prefecture, in April 2023, and are actively engaged in research and in the nurturing of high-level human talent involved in the research.
